This inventor holds 1 USPTO granted patent. Top assignee: Mect Corporation. Active years: 1988.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1988
Title: Ryuji Niwa: Innovator in Arteriosclerosis Treatment
Introduction
Ryuji Niwa is a notable inventor based in Tokorozawa, Japan. He has made significant contributions to the field of medicine, particularly in the treatment of arteriosclerosis. His innovative approach has led to the development of a unique medicament that addresses this serious health condition.
Latest Patents
Ryuji Niwa holds a patent for a method and composition for treating arteriosclerosis. This medicament comprises a pyrimido [2,1-b] benzothiazole derivative, which showcases his commitment to advancing medical treatments. His patent is a testament to his innovative thinking and dedication to improving patient outcomes.
Career Highlights
Throughout his career, Ryuji Niwa has been associated with Mect Corporation, where he has been able to apply his expertise in developing medical solutions. His work has not only contributed to the company's success but has also had a positive impact on the healthcare industry.
Collaborations
Ryuji Niwa has collaborated with esteemed colleagues such as Nobuya Katagiri and Tetsuzo Kato. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Ryuji Niwa's contributions to the field of medicine, particularly in treating arteriosclerosis, highlight his role as an influential inventor. His innovative patent and collaborations with other professionals underscore his commitment to advancing healthcare solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile